Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, an organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs.

e is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He also conducts Oncology and Hematology Clinical Trials in SSA.

He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Breast Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA.

He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee and a member of ASCO’s board of directors. He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States’ National Cancer Institute’s Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International ‘s 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He is the current Interim President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, AORTIC, KESHO, Africa Cancer ECHO, APCA amongst others.

e did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States.

A medical doctor and global health physician with a 17-year career experience in medical
practice, clinical and preventive oncology, cancer policy formulation and programming at the
Ministry of Health in Kenya. Currently serves as the Head of the National Cancer Control
Program and Co-Chair of the National Cancer Taskforce.

She is passionate about improving access to care across the cancer care continuum and health
system strengthening to ensure delivery of services in a timely, safe and effective manner.
She has led the formulation and implementation of various cancer policy documents and
guidelines including the Breast Cancer Screening and Early Diagnosis Action Plan 2021-2025.
Globally, she has also contributed to the drafting of the Global Strategy for Elimination of
Cervical Cancer abd the Global Breast Health Initiative. She has interest in cancer research
especially in the area of preventive oncology and behavioural studies and have published a
number of papers in various peer-reviewed journals. She is a member of the Kenya Medical
Association, the Africa Cancer Coalition, the Kenya Red Cross and the Kenya Society of
Haematology and Oncology.

Dr Mogere is a Consultant Neurosurgery and Neurovascular specialist, Assistant Professor and Programme Director at Aga Khan University, Nairobi.

Dr Tracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching, Research and Referral Hospital.

She holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.

Dr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.

Dr. Nanji is a surgeon-scientist with the Department of Surgery at Queen’s University. He has earned a MD, PhD, and designation as a clinical investigator through the Royal College of Physicians and Surgeons. He has dual fellowship accreditation in hepatobiliary and pancreatic surgery as well as multi-visceral organ transplantation. His clinical training and research interests have provided opportunities to work in several institutions including the Universities of British Columbia, Alberta and Toronto as well as Emory University, Kings College Hospital in London, UK and the National Aeronautics and Space Administration (NASA). His current research interests in oncology complement his clinical practice in the surgical treatment of hepatobiliary and pancreatic malignancies. He conducts translational research in the epigenetics of human liver cancer to better risk stratify and treat patients with liver cancer. He also conducts epidemiological and health services research in HPB malignancies through the Cancer Research Institute at Queen’s University. More recently, he is completing a Master’s degree in Global Surgery to advance his clinical and academic interests in global surgical development. Outside of his professional commitments, he enjoys playing guitar, martial arts and spending time outdoors with his wife and 3 children.

Dr Bor is a public health specialist with a special interest in non-communicable diseases (NCDs) and 15 years professional experience in the Kenyan public health sector, including over 10 years in clinical care and hospital management. She is currently the Lead for the Cancer Prevention and Early Detection Pillar in the National Cancer Control Program (NCCP), Ministry of Health. Her role involves developing and implementing policies and programs towards the achievement of the National Cancer Control Strategy. She coordinated the development of the National Cancer Screening Guidelines in 2018 and is keen to see through the advancement of a harmonized cancer screening program nationwide. She also coordinates the National Technical Working Group on Cancer Prevention, Early Detection & Screening. Dr Bor holds a Master of Science in Global Health & Non-Communicable Diseases from University of Edinburgh.